Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PLX

Pyrolyx (PLX)

Pyrolyx AG
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:PLX
DateTimeSourceHeadlineSymbolCompany
11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest EliminationsAMEX:PLXProtalix BioTherapeutics Inc.
11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-AMEX:PLXProtalix BioTherapeutics Inc.
11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-AMEX:PLXProtalix BioTherapeutics Inc.
11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest SalesAMEX:PLXProtalix BioTherapeutics Inc.
11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest PurchasesAMEX:PLXProtalix BioTherapeutics Inc.
11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-AMEX:PLXProtalix BioTherapeutics Inc.
02/05/20136:43PMDow Jones NewsU.S. HOT STOCKS: Zynga, Take-Two, Shutterfly Active in Late TradingAMEX:PLXProtalix BioTherapeutics Inc.
02/05/20132:21PMDow Jones NewsU.S. HOT STOCKS: Yum Brands, McGraw-Hill, Virgin Media, OpexaAMEX:PLXProtalix BioTherapeutics Inc.
02/05/201312:40PMDow Jones NewsProtalix Confirms It's Considering Options; Shares SurgeAMEX:PLXProtalix BioTherapeutics Inc.
06/11/20128:29AMDow Jones NewsProtalix Gets $25 Million Milestone Payment For Rare-Disease DrugAMEX:PLXProtalix BioTherapeutics Inc.
05/01/20126:05PMDow Jones NewsUPDATE: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
05/01/20125:37PMDow Jones NewsCORRECT: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
05/01/20125:07PMDow Jones NewsFDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
10/15/200911:50AMDow Jones NewsUPDATE: Protalix Gaucher's Treatment Passes Late-Stage TrialAMEX:PLXProtalix BioTherapeutics Inc.
10/15/20096:56AMDow Jones NewsProtalix Gaucher's Treatment Passes Late-Stage TrialAMEX:PLXProtalix BioTherapeutics Inc.
08/31/20092:39PMDow Jones NewsGenzyme Top Seller Faces Competition Amid Supply IssuesAMEX:PLXProtalix BioTherapeutics Inc.
08/25/20099:06AMDow Jones NewsFDA Gives Fast-Track Status To Protalix Drug For Gaucher'sAMEX:PLXProtalix BioTherapeutics Inc.
08/17/20098:35AMDow Jones NewsFDA OKs Protalix's Treatment Protocol Drug For Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
08/03/200911:54AMDow Jones NewsIcagen Rallies, Genzyme Slides On FDA UpdatesAMEX:PLXProtalix BioTherapeutics Inc.
08/03/20093:05AMDow Jones NewsShire Says FDA Permits Vela Use; Reports Phase III SuccessAMEX:PLXProtalix BioTherapeutics Inc.
07/16/20095:12AMDow Jones NewsUPDATE: Shire Gets Fast-Track Approval For Gaucher-Treating DrugAMEX:PLXProtalix BioTherapeutics Inc.
07/16/20093:25AMDow Jones NewsShire Gets Fast-Track Approval For Gaucher-Treating DrugAMEX:PLXProtalix BioTherapeutics Inc.
07/07/20095:11AMDow Jones NewsUPDATE:Shire Seeks FDA OK To Provide Vela Amid Drug ShortageAMEX:PLXProtalix BioTherapeutics Inc.
 Showing the most relevant articles for your search:ASX:PLX

Your Recent History

Delayed Upgrade Clock